Advanced Type 2 Diabetes: When diet, exercise, and dual-drug therapies (like Metformin + Gliclazide alone) aren't enough to control blood sugar. HbA1c Reduction: To lower long-term blood glucose averages. Severe Insulin Resistance: To help the body?s cells better utilize the insulin they already produce.

This combination covers all the bases for glucose control: Gliclazide: Acts on the pancreas, "nudging" the beta cells to release more insulin into the bloodstream. Metformin (SR): Primarily tells the liver to stop pumping out extra glucose and makes the gut absorb less sugar from food. The SR (Sustained Release) ensures this happens gradually to protect your stomach. Pioglitazone: Works at the cellular level to "unlock" muscle and fat cells, making them highly sensitive to insulin.

Hypoglycemia (Low Blood Sugar): The most common risk due to the Gliclazide component. Weight Gain: Both Pioglitazone and Gliclazide can lead to an increase in body weight. Fluid Retention (Edema): Pioglitazone may cause swelling in the ankles or legs. Stomach Issues: Bloating, gas, or a metallic taste in the mouth (common with Metformin). Bone Health: Long-term use of Pioglitazone has been linked to a slightly higher risk of bone fractures, especially in women.